2022 Volume 8 - Issue 1
-
March 31, 2022 Research Article
Abstract Two years have passed since the beginning of the SARS-CoV-2 pandemic and the continual emergence of SARS-CoV-2 mutated viral strains has led to continual re-evaluation of the current therapeutic options. Herein we continued an analysis of the interac.....
-
October 12, 2022 Perspective
Abstract Cyclophosphamide (CP) is one of the oldest anticancer drugs, but one that is also highly effective by today’s standards. The theoretical idea for the development of CP was to administer a nontoxic prodrug that liberates in tumor tissue nitrog.....
